Improvement of extreme hypoxemia during end-stage congenital heart disease using nasal nitric oxide.
Cholley
B P
BP
Department of Anesthesiology and Intensive Care, Hôpital Lariboisière, Paris, France.
Hilbert
U
U
Guinard
N
N
Mateo
J
J
Payen
D
D
D000281:Administration, Intranasal; D000328:Adult; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications*; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy* / Q000209:etiology; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use*
D009569:Nitric Oxide